Life sciences organizations have become some of the world’s most watched businesses and the industry as a whole is facing heightened scrutiny in light of the COVID-19 pandemic. As a result, there are many legal and business factors facing life sciences companies, including increasingly complex transactional and regulatory issues as well as enforcement risks.

Join our cross-functional team in person for a Life Sciences Boot Camp, which will bring together seasoned lawyers from across our practice groups for a half-day CLE program tailored to life sciences in-house counsel.

Explore the agenda:
12:00 – 12:30 pm | Lunch/Registration
12:30 – 12:35 pm | Welcome & Opening Remarks
12:40 – 1:10 pm | From the Frontlines: First-Hand Perspectives from Leading In-House Counsel
1:15 – 2:05 pm | An Industry Under Scrutiny: In-House Compliance and Government Oversight
2:10 – 2:25 pm | Networking Break
2:30 – 3:20 pm | Evolving Cybersecurity and Data Considerations for Life Sciences Companies
3:25 – 4:15 pm | FDA Exclusivities & IP Considerations
4:15 – 5:00 pm | M&A: Pre and Post-Acquisition Key Considerations
5:00 – 6:00 pm | Networking Reception

CLE CREDIT PENDING
Minimum continuing legal education (MCLE) credit is pending in California, Illinois and New York. A Multi-Jurisdiction Certificate of Attendance will be made available to participants requesting MCLE credit in all other jurisdictions. To be eligible to earn a CLE certificate, attendees must sign in/out on-site at the symposium. For more information, please contact Julia Berman. Please be advised McDermott has the right to restrict attendance and may limit participation in this event.

COVID DISCLAIMER
If you have recently contracted COVID-19, please do not attend the event unless you will be past the isolation period at the time of the event. Only vaccinated personnel of McDermott Will & Emery will be attending McDermott-sponsored client events. We ask everyone to monitor their own health closely and to please stay home if they are experiencing any symptoms of COVID-19. By participating you assume any risk related to COVID-19.